Alkem Laboratories informs about company updates

30 Mar 2017 Evaluate

In furtherance to the intimation captioned Update on US FDA Inspection at Alkems Ankaleshwar API Facility dated 12th December, 2016; Alkem Laboratories has informed that the US FDA has issued an Establishment Inspection Report (EIR) for the Company’s Active Pharmaceutical Ingredient (API) manufacturing facility located at Ankaleshwar, India which was inspected in December 2016. The inspection has now been closed by the US FDA. In response to the Form 483 issued by the US FDA, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The US FDA has reviewed the CAPA and has found them acceptable.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5419.75 -12.10 (-0.22%)
23-Dec-2024 10:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.80
Dr. Reddys Lab 1342.90
Cipla 1472.00
Lupin 2156.35
Zydus Lifesciences 969.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.